Literature DB >> 21212797

Clusterin secreted by astrocytes enhances neuronal differentiation from human neural precursor cells.

O Cordero-Llana1, S A Scott, S L Maslen, J M Anderson, J Boyle, R-R Chowhdury, P Tyers, R A Barker, C M Kelly, A E Rosser, E Stephens, S Chandran, M A Caldwell.   

Abstract

Neuronal differentiation from expanded human ventral mesencephalic neural precursor cells (NPCs) is very limited. Astrocytes are known to secrete neurotrophic factors, and so in order to enhance neuronal survival from NPCs, we tested the effect of regional astrocyte-conditioned medium (ACM) from the rat cortex, hippocampus and midbrain on this process. Human NPC's were expanded in FGF-2 before differentiation for 1 or 4 weeks in ACM. The results show that ACM from the hippocampus and midbrain increase the number of neurons from expanded human NPCs, an effect that was not observed with cortical ACM. In addition, both hippocampal and midbrain ACM increased the number and length of phosphorylated neurofilaments. MALDI-TOF analysis used to determine differences in media revealed that although all three regional ACMs had cystatin C, α-2 macroglobulin, extracellular matrix glycoprotein and vimentin, only hippocampal and midbrain ACM also contained clusterin, which when immunodepleted from midbrain ACM eliminated the observed effects on neuronal differentiation. Furthermore, clusterin is a highly glycosylated protein that has no effect on cell proliferation but decreases apoptotic nuclei and causes a sustained increase in phosphorylated extracellular signal-regulated kinase, implicating its role in cell survival and differentiation. These findings further reveal differential effects of regional astrocytes on NPC behavior and identify clusterin as an important mediator of NPC-derived neuronal survival and differentiation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21212797      PMCID: PMC3131926          DOI: 10.1038/cdd.2010.169

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  40 in total

1.  Inhibition of post-ischemic brain injury by clusterin overexpression.

Authors:  P Wehrli; Y Charnay; P Vallet; G Zhu; J Harmony; B Aronow; J Tschopp; C Bouras; I Viard-Leveugle; L E French; P Giannakopoulos
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

2.  Regional specification of rodent and human neurospheres.

Authors:  T Ostenfeld; Etienne Joly; Yu Tzu Tai; Anna Peters; Maeve Caldwell; Eric Jauniaux; C N Svendsen
Journal:  Brain Res Dev Brain Res       Date:  2002-03-31

3.  Growth factors regulate the survival and fate of cells derived from human neurospheres.

Authors:  M A Caldwell; X He; N Wilkie; S Pollack; G Marshall; K A Wafford; C N Svendsen
Journal:  Nat Biotechnol       Date:  2001-05       Impact factor: 54.908

4.  Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia.

Authors:  B H Han; R B DeMattos; L L Dugan; J S Kim-Han; R P Brendza; J D Fryer; M Kierson; J Cirrito; K Quick; J A Harmony; B J Aronow; D M Holtzman
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

Review 5.  Mammalian neural stem cells.

Authors:  F H Gage
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

6.  Rat alpha1-macroglobulin enhances nerve growth factor-promoted neurite outgrowth, TrkA phosphorylation, and gene expression of pheochromocytoma PC12 cells.

Authors:  P G Lee; P H Koo
Journal:  J Neurochem       Date:  2000-01       Impact factor: 5.372

7.  FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor.

Authors:  P Taupin; J Ray; W H Fischer; S T Suhr; K Hakansson; A Grubb; F H Gage
Journal:  Neuron       Date:  2000-11       Impact factor: 17.173

8.  Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease.

Authors:  Jean-Charles Lambert; Simon Heath; Gael Even; Dominique Campion; Kristel Sleegers; Mikko Hiltunen; Onofre Combarros; Diana Zelenika; Maria J Bullido; Béatrice Tavernier; Luc Letenneur; Karolien Bettens; Claudine Berr; Florence Pasquier; Nathalie Fiévet; Pascale Barberger-Gateau; Sebastiaan Engelborghs; Peter De Deyn; Ignacio Mateo; Ana Franck; Seppo Helisalmi; Elisa Porcellini; Olivier Hanon; Marian M de Pancorbo; Corinne Lendon; Carole Dufouil; Céline Jaillard; Thierry Leveillard; Victoria Alvarez; Paolo Bosco; Michelangelo Mancuso; Francesco Panza; Benedetta Nacmias; Paola Bossù; Paola Piccardi; Giorgio Annoni; Davide Seripa; Daniela Galimberti; Didier Hannequin; Federico Licastro; Hilkka Soininen; Karen Ritchie; Hélène Blanché; Jean-François Dartigues; Christophe Tzourio; Ivo Gut; Christine Van Broeckhoven; Annick Alpérovitch; Mark Lathrop; Philippe Amouyel
Journal:  Nat Genet       Date:  2009-09-06       Impact factor: 38.330

9.  Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis.

Authors:  L McLaughlin; G Zhu; M Mistry; C Ley-Ebert; W D Stuart; C J Florio; P A Groen; S A Witt; T R Kimball; D P Witte; J A Harmony; B J Aronow
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

10.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.

Authors:  Denise Harold; Richard Abraham; Paul Hollingworth; Rebecca Sims; Amy Gerrish; Marian L Hamshere; Jaspreet Singh Pahwa; Valentina Moskvina; Kimberley Dowzell; Amy Williams; Nicola Jones; Charlene Thomas; Alexandra Stretton; Angharad R Morgan; Simon Lovestone; John Powell; Petroula Proitsi; Michelle K Lupton; Carol Brayne; David C Rubinsztein; Michael Gill; Brian Lawlor; Aoibhinn Lynch; Kevin Morgan; Kristelle S Brown; Peter A Passmore; David Craig; Bernadette McGuinness; Stephen Todd; Clive Holmes; David Mann; A David Smith; Seth Love; Patrick G Kehoe; John Hardy; Simon Mead; Nick Fox; Martin Rossor; John Collinge; Wolfgang Maier; Frank Jessen; Britta Schürmann; Reinhard Heun; Hendrik van den Bussche; Isabella Heuser; Johannes Kornhuber; Jens Wiltfang; Martin Dichgans; Lutz Frölich; Harald Hampel; Michael Hüll; Dan Rujescu; Alison M Goate; John S K Kauwe; Carlos Cruchaga; Petra Nowotny; John C Morris; Kevin Mayo; Kristel Sleegers; Karolien Bettens; Sebastiaan Engelborghs; Peter P De Deyn; Christine Van Broeckhoven; Gill Livingston; Nicholas J Bass; Hugh Gurling; Andrew McQuillin; Rhian Gwilliam; Panagiotis Deloukas; Ammar Al-Chalabi; Christopher E Shaw; Magda Tsolaki; Andrew B Singleton; Rita Guerreiro; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Karl-Heinz Jöckel; Norman Klopp; H-Erich Wichmann; Minerva M Carrasquillo; V Shane Pankratz; Steven G Younkin; Peter A Holmans; Michael O'Donovan; Michael J Owen; Julie Williams
Journal:  Nat Genet       Date:  2009-09-06       Impact factor: 38.330

View more
  16 in total

1.  The chaperone protein clusterin may serve as a cerebrospinal fluid biomarker for chronic spinal cord disorders in the dog.

Authors:  Intan N F Shafie; Mark McLaughlin; Richard Burchmore; Mary Ann A Lim; Paul Montague; Pamela E J Johnston; Jacques Penderis; Thomas J Anderson
Journal:  Cell Stress Chaperones       Date:  2013-08-29       Impact factor: 3.667

2.  A novel compound, denosomin, ameliorates spinal cord injury via axonal growth associated with astrocyte-secreted vimentin.

Authors:  Kiyoshi Teshigawara; Tomoharu Kuboyama; Michiko Shigyo; Aiko Nagata; Kenji Sugimoto; Yuji Matsuya; Chihiro Tohda
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

Review 3.  Induced pluripotency and direct reprogramming: a new window for treatment of neurodegenerative diseases.

Authors:  Rui Li; Ye Bai; Tongtong Liu; Xiaoqun Wang; Qian Wu
Journal:  Protein Cell       Date:  2013-05-20       Impact factor: 14.870

4.  Effect of Ionizing Radiation on Transcriptome during Neural Differentiation of Human Embryonic Stem Cells.

Authors:  Burk W Loeliger; Christine Hanu; Irina V Panyutin; Roberto Maass-Moreno; Paul Wakim; William F Pritchard; Ronald D Neumann; Igor G Panyutin
Journal:  Radiat Res       Date:  2020-03-27       Impact factor: 2.841

5.  Neuroprotection by leptin in a rat model of permanent cerebral ischemia: effects on STAT3 phosphorylation in discrete cells of the brain.

Authors:  D Amantea; C Tassorelli; R Russo; F Petrelli; L A Morrone; G Bagetta; M T Corasaniti
Journal:  Cell Death Dis       Date:  2011-12-08       Impact factor: 8.469

6.  CNF1 improves astrocytic ability to support neuronal growth and differentiation in vitro.

Authors:  Fiorella Malchiodi-Albedi; Silvia Paradisi; Michela Di Nottia; Daiana Simone; Sara Travaglione; Loredana Falzano; Marco Guidotti; Claudio Frank; Alessandro Cutarelli; Alessia Fabbri; Carla Fiorentini
Journal:  PLoS One       Date:  2012-04-16       Impact factor: 3.240

7.  Extracellular vimentin interacts with insulin-like growth factor 1 receptor to promote axonal growth.

Authors:  Michiko Shigyo; Tomoharu Kuboyama; Yusuke Sawai; Masahito Tada-Umezaki; Chihiro Tohda
Journal:  Sci Rep       Date:  2015-07-14       Impact factor: 4.379

8.  Multivariate proteomic analysis of the cerebrospinal fluid of patients with peripheral neuropathic pain and healthy controls - a hypothesis-generating pilot study.

Authors:  Emmanuel Bäckryd; Bijar Ghafouri; Anders K Carlsson; Patrik Olausson; Björn Gerdle
Journal:  J Pain Res       Date:  2015-07-01       Impact factor: 3.133

9.  Astrocyte-Secreted Factors Selectively Alter Neural Stem and Progenitor Cell Proliferation in the Fragile X Mouse.

Authors:  Mary Sourial; Laurie C Doering
Journal:  Front Cell Neurosci       Date:  2016-05-18       Impact factor: 5.505

Review 10.  Human stem cell-derived astrocytes and their application to studying Nrf2-mediated neuroprotective pathways and therapeutics in neurodegeneration.

Authors:  Kunal Gupta; Siddharthan Chandran; Giles E Hardingham
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.